IS1901B - Efnasambönd til að hindra magasýruseytrun - Google Patents

Efnasambönd til að hindra magasýruseytrun

Info

Publication number
IS1901B
IS1901B IS5148A IS5148A IS1901B IS 1901 B IS1901 B IS 1901B IS 5148 A IS5148 A IS 5148A IS 5148 A IS5148 A IS 5148A IS 1901 B IS1901 B IS 1901B
Authority
IS
Iceland
Prior art keywords
compounds
gastric acid
acid secretion
inhibit gastric
inhibit
Prior art date
Application number
IS5148A
Other languages
English (en)
Other versions
IS5148A (is
Inventor
Amin Kosrat
Dahlström Mikael
Nordberg Peter
Starke Ingemar
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of IS5148A publication Critical patent/IS5148A/is
Publication of IS1901B publication Critical patent/IS1901B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS5148A 1997-02-25 1999-08-05 Efnasambönd til að hindra magasýruseytrun IS1901B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9700661A SE9700661D0 (sv) 1997-02-25 1997-02-25 New compounds
PCT/SE1998/000275 WO1998037080A1 (en) 1997-02-25 1998-02-17 Compounds for inhibition of gastric acid secretion

Publications (2)

Publication Number Publication Date
IS5148A IS5148A (is) 1999-08-05
IS1901B true IS1901B (is) 2003-11-20

Family

ID=20405920

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5148A IS1901B (is) 1997-02-25 1999-08-05 Efnasambönd til að hindra magasýruseytrun

Country Status (32)

Country Link
US (1) US6265415B1 (is)
EP (1) EP0971920B1 (is)
JP (1) JP2001512477A (is)
KR (1) KR20000075622A (is)
CN (1) CN1100056C (is)
AR (1) AR011134A1 (is)
AT (1) ATE218569T1 (is)
AU (1) AU723389B2 (is)
BR (1) BR9807457A (is)
CA (1) CA2280008A1 (is)
CZ (1) CZ291681B6 (is)
DE (1) DE69805787T2 (is)
DK (1) DK0971920T3 (is)
EE (1) EE04016B1 (is)
ES (1) ES2178169T3 (is)
HU (1) HUP0000720A3 (is)
ID (1) ID22218A (is)
IL (1) IL131122A0 (is)
IS (1) IS1901B (is)
MY (1) MY118822A (is)
NO (1) NO313009B1 (is)
NZ (1) NZ336878A (is)
PL (1) PL190379B1 (is)
PT (1) PT971920E (is)
RU (1) RU2193036C2 (is)
SE (1) SE9700661D0 (is)
SK (1) SK283903B6 (is)
TR (1) TR199902060T2 (is)
TW (1) TW568907B (is)
UA (1) UA64741C2 (is)
WO (1) WO1998037080A1 (is)
ZA (1) ZA981134B (is)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
JPH10502365A (ja) * 1994-07-01 1998-03-03 リカン・リミテッド ヘリコバクタータンパク質およびワクチン
WO1997025429A1 (en) * 1996-01-04 1997-07-17 Rican Limited Helicobacter pylori bacterioferritin
SE9602286D0 (sv) 1996-06-10 1996-06-10 Astra Ab New compounds
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
DE10001037C1 (de) 2000-01-13 2001-12-13 Byk Gulden Lomberg Chem Fab Verfahren und Zwischenprodukte zur Herstellung von Imidazopyridinen
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
JP2005506322A (ja) * 2001-08-31 2005-03-03 カイロン ソチエタ ア レスポンサビリタ リミタータ Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉワクチン接種
DE10145457A1 (de) 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
ATE378336T1 (de) 2002-09-19 2007-11-15 Schering Corp Imidazopyridine als hemmstoffe cyclin abhängiger kinasen
CA2517256C (en) * 2003-02-26 2013-04-30 Sugen, Inc. Aminoheteroaryl compounds as protein kinase inhibitors
PT1606261E (pt) 2003-03-10 2010-01-11 Nycomed Gmbh Novo processo para a preparação de roflumilast
SE0301904D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
WO2005026164A1 (en) * 2003-09-18 2005-03-24 Altana Pharma Ag Pharmacologically active imidazo[4,5-c]pyridines
EP1682133A1 (en) 2003-11-03 2006-07-26 AstraZeneca AB Imidazo 1,2-a pyridine derivatives for the treatment of silent gastro-esophageal reflux
SE0303451D0 (sv) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
TW200606163A (en) * 2004-04-22 2006-02-16 Eisai Co Ltd Imidazopyridine compound
ATE527258T1 (de) 2004-07-28 2011-10-15 Takeda Pharmaceutical Pyrroloä2,3-cüpyridinverbindung, verfahren zu deren herstellung und anwendung
DK1784404T3 (da) 2004-09-03 2012-02-13 Yuhan Corp Pyrrolo[2,3-c]pyridinderivater samt fremgangsmåder til deres fremstilling
KR100958828B1 (ko) 2004-09-03 2010-05-24 주식회사유한양행 피롤로[3,2-ｂ]피리딘 유도체 및 그의 제조방법
MX2007002214A (es) 2004-09-03 2007-05-07 Yuhan Corp Derivados de pirrolo[3,2-c]piridina y procesos para su preparacion.
KR101068355B1 (ko) * 2005-03-09 2011-09-28 주식회사유한양행 신규의 이미다조[1,2-ａ]피리딘 유도체 및 그의 제조방법
US8663694B2 (en) * 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast
PE20061110A1 (es) * 2005-03-24 2006-10-20 Glaxo Group Ltd Derivados de imidazopiridina como antagonistas de la bomba de acido (apa)
DE602006018354D1 (de) 2005-12-05 2010-12-30 Pfizer Prod Inc Verfahren zur behandlung von abnormalem zellwachstum
KR101146852B1 (ko) 2005-12-05 2012-05-16 화이자 프로덕츠 인크. Ｃ?ｍｅｔ／ｈｇｆｒ 억제제의 다형체
FR2903107B1 (fr) * 2006-07-03 2008-08-22 Sanofi Aventis Sa Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique
EP2496578A4 (en) * 2009-11-05 2013-08-21 Univ Notre Dame Du Lac IMIDAZO [1,2-A] PYRIDINE COMPOUNDS, THEIR SYNTHESIS AND METHODS OF USE THEREOF
CA2836202A1 (en) 2011-05-30 2012-12-06 Astellas Pharma Inc. Imidazopyridine compounds
CA2891976C (en) * 2012-11-30 2020-07-21 Astellas Pharma Inc. Imidazopyridine compounds
CN120117960A (zh) * 2025-05-12 2025-06-10 天津全和诚科技有限责任公司 一种杂质化合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
HU201551B (en) * 1988-02-03 1990-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 4-oxo-4h-pyrido(1,2-a)pyrimidine-3-carboxylic acid amide derivatives and pharmaceutical compositions comprising same

Also Published As

Publication number Publication date
TW568907B (en) 2004-01-01
CZ301499A3 (cs) 2000-02-16
ID22218A (id) 1999-09-16
EP0971920B1 (en) 2002-06-05
NO994078L (no) 1999-08-24
AU723389B2 (en) 2000-08-24
EP0971920A1 (en) 2000-01-19
SK283903B6 (sk) 2004-04-06
SK109999A3 (en) 2000-01-18
HUP0000720A2 (hu) 2000-10-28
MY118822A (en) 2005-01-31
CN1100056C (zh) 2003-01-29
KR20000075622A (ko) 2000-12-26
ZA981134B (en) 1998-08-25
AR011134A1 (es) 2000-08-02
DE69805787D1 (de) 2002-07-11
NZ336878A (en) 2001-05-25
IS5148A (is) 1999-08-05
HK1024248A1 (en) 2000-10-05
PL190379B1 (pl) 2005-12-30
RU2193036C2 (ru) 2002-11-20
SE9700661D0 (sv) 1997-02-25
CN1248257A (zh) 2000-03-22
NO313009B1 (no) 2002-07-29
WO1998037080A1 (en) 1998-08-27
DK0971920T3 (da) 2002-09-16
EE04016B1 (et) 2003-04-15
TR199902060T2 (xx) 2000-02-21
IL131122A0 (en) 2001-01-28
AU6314798A (en) 1998-09-09
BR9807457A (pt) 2000-04-25
ES2178169T3 (es) 2002-12-16
CA2280008A1 (en) 1998-08-27
JP2001512477A (ja) 2001-08-21
PL335485A1 (en) 2000-04-25
ATE218569T1 (de) 2002-06-15
NO994078D0 (no) 1999-08-24
DE69805787T2 (de) 2003-01-02
CZ291681B6 (cs) 2003-04-16
UA64741C2 (uk) 2004-03-15
US6265415B1 (en) 2001-07-24
HUP0000720A3 (en) 2001-01-29
MX9907650A (es) 2002-12-13
PT971920E (pt) 2002-11-29
EE9900367A (et) 2000-04-17

Similar Documents

Publication Publication Date Title
IS1901B (is) Efnasambönd til að hindra magasýruseytrun
DE69918278D1 (de) Substituierte indolalkansäure
ID20809A (id) Asam diaminokarboksilat tersubstitusi
EE200000321A (et) Uudsed ühendid
ID20807A (id) Asam sulfonilaminokarboksilat
DE69828371D1 (de) Wasserdichter Verbinder
DK1100769T3 (da) Aminomethylcarboxylsyrederivater
DK0944386T3 (da) Sulfonsyre- eller sulfonylamino-N-(heteroaralkyl)-azaheterocyclylamid-forbindelser
ID28810A (id) Senyawa-senyawa amida-omega asam n-arilsulfonilamino
NO991561D0 (no) 3-alkoksyisoksazol-4-yl-substituerte 2-aminokarboksylsyreforbindelser
DE69838190D1 (de) Wasserdichter Verbinder
NO306159B1 (no) 5-arylisoksazol-4-substituerte 2-aminokarboksylsyreforbindelser
PT1228026E (pt) Compostos relacionados com o acido 15-hidroxieicosatetraenoico
ID24327A (id) Produksi senyawa-senyawa avermektin
EE200000239A (et) Uued metüleenbisfosfoonhappe derivaadid
FI973826L (fi) Suoritettavat ohjelmat
FI972410L (fi) Mahahapon eritystä ehkäisevät yhdisteet
SE9702775D0 (sv) Novel compounds
NO974296D0 (no) Aminosyreforbindelse
SI0971920T1 (en) Compounds for inhibition of gastric acid secretion
SE9701100D0 (sv) Novel compounds
SE9701767D0 (sv) Novel compounds
SE9702197D0 (sv) Novel compounds
SE9702198D0 (sv) Novel compounds
SE9702652D0 (sv) Novel compounds